New class of small molecule drug, SI-2, has potential for improving cancer treatment

Posted by on April 20, 2016 2:43 pm
Categories: health

Cancer cells communicate with their environment through cell molecules that pass on signals to the inside of the cell. SI-2 is a potent small-molecule inhibitor to drug the undruggable steroid receptor coactivator-3.

Leave a Reply

Your email address will not be published. Required fields are marked *